A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease

Expert Opinion on Drug Safety
Konstantinos PapamichaelL Peyrin-Biroulet

Abstract

Anti-tumor necrosis factor-alpha (TNF-α) therapy has revolutionized the medical treatment of Crohn's disease (CD). Nevertheless, anti-TNF-α therapy has been associated with serious adverse events (SAE) raising safety concerns. This review focuses on the safety profile of anti-TNF-α agents in CD. Areas covered: We performed a literature search until August 2015 to collect safety data on infliximab, adalimumab and certolizumab pegol monotherapy or combined with immunomodulators (IMM). We have mainly focused on infections and malignancies. Safety in pregnancy, the elderly and children are also presented. Expert opinion: Available data in CD suggest that anti-TNF-α monotherapy or in combination with IMM is relatively safe, although it may be associated with an elevated risk of serious infections, skin cancer and lymphoma. However, as this data derive mainly from cohort studies, post-marketing registries, and meta-analyses of RCTs, often characterized by inherited methodological weaknesses that may hinder their validity, data from large, statistically powered, prospective studies of sufficient follow up are required to define the actual risk of SAE during anti-TNF-α therapy in IBD. The role of therapeutic drug monitoring in predicti...Continue Reading

References

Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Jan 16, 2003·The American Journal of Gastroenterology·Michael C StephensRobert N Baldassano
Oct 12, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bruce E SandsUNKNOWN ACCENT II Study
Sep 7, 2005·Gastroenterology·Stefan SchreiberUNKNOWN CDP870 Crohn's Disease Study Group
Apr 19, 2006·Gastroenterology·Marc LémannUNKNOWN Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID)
May 2, 2007·Annals of Internal Medicine·William J SandbornPaul F Pollack
Jul 20, 2007·The New England Journal of Medicine·William J SandbornUNKNOWN PRECISE 1 Study Investigators
Jul 20, 2007·The New England Journal of Medicine·Stefan SchreiberUNKNOWN PRECISE 2 Study Investigators
Feb 26, 2008·Gastroenterology·Murat TorunerLaurence J Egan
Jun 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurent Peyrin-BirouletJean-Frédéric Colombel
May 13, 2009·Inflammatory Bowel Diseases·Jean-Frédéric ColombelAlexandra T Cardoso
Jun 18, 2009·The American Journal of Gastroenterology·Josh MarehbianWilliam J Sandborn
Jun 30, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Corey A SiegelBruce E Sands
Sep 3, 2009·The American Journal of Gastroenterology·Joel R RoshJeffrey S Hyams
Dec 17, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Millie D LongMichael D Kappelman
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Aug 5, 2010·Inflammatory Bowel Diseases·Livia BianconeFrancesco Pallone
Aug 24, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-François RahierUNKNOWN Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)
Sep 18, 2010·Inflammatory Bowel Diseases·Jason M SwogerWilliam J Sandborn
Oct 5, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David S KotlyarGary R Lichtenstein
Oct 19, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mario CottoneAmbrogio Orlando
Jun 7, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornGeert R D'Haens
Jun 29, 2011·Gastroenterology·Laurent Peyrin-BirouletUNKNOWN Cesame Study Group
Aug 11, 2011·Inflammatory Bowel Diseases·Fabian SchnitzlerPaul Rutgeerts
Oct 28, 2011·The American Journal of Gastroenterology·Lisa J HerrintonJames E Allison
Feb 14, 2012·Journal of Crohn's & Colitis·Mamoru WatanabeUNKNOWN Study Investigators
Feb 22, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Christina HaAsher Kornbluth
Apr 5, 2012·Scandinavian Journal of Gastroenterology·Ase RiisReidar Fossmark
May 16, 2012·Gastroenterology·Millie D LongMichael D Kappelman
May 16, 2012·Journal of Pediatric Gastroenterology and Nutrition·Gigi Veereman-WautersUNKNOWN ESPGHAN IBD Porto Group
Jun 9, 2012·Journal of Crohn's & Colitis·Aranzazu Jauregui-AmezagaJulián Panés
Jul 4, 2012·Nature Reviews. Gastroenterology & Hepatology·Isabelle Cleynen, Séverine Vermeire
Jul 27, 2012·Epidemiology and Psychiatric Sciences·M P HengartnerW F Gattaz
Aug 15, 2012·The American Journal of Gastroenterology·Gary R LichtensteinWilliam J Sandborn
Oct 12, 2012·Digestive Diseases and Sciences·Jennifer L SeminerioWilliam J Sandborn
Dec 4, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uma MahadevanMaria T Abreu
Apr 5, 2013·Inflammatory Bowel Diseases·Emma J EshuisCyriel Y Ponsioen

❮ Previous
Next ❯

Citations

Jun 23, 2016·Expert Opinion on Biological Therapy·Lieven PouillonLaurent Peyrin-Biroulet
Jul 14, 2016·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Chaya ShwaartzCelia M Divino
Nov 1, 2016·Journal of Crohn's & Colitis·Lydia C T BuerMarte Lie Høivik
Jun 22, 2018·International Journal of Colorectal Disease·Patrícia Guedes GarciaJulio Maria Fonseca Chebli
Oct 14, 2016·Hypertension·Michaela GolicRalf Dechend
Apr 27, 2019·Expert Opinion on Drug Safety·Aviv PudipeddiRupert Wl Leong
Nov 30, 2019·Inflammatory Bowel Diseases·Jiafei ChengJiande D Z Chen
May 16, 2020·Current Opinion in Rheumatology·Konstantinos Papamichael, Adam S Cheifetz
Feb 23, 2020·Gut·Konstantinos PapamichaelPeter M Irving
Dec 2, 2017·Expert Opinion on Biological Therapy·Mohammed Razvi, Mark Lazarev
Jul 8, 2018·Journal of Gastroenterology·Hai Yun Shi, Siew Chien Ng
Dec 30, 2020·BMJ Case Reports·Andrew DermawanSherman Picardo
Oct 20, 2020·Neuromuscular Disorders : NMD·Louise GaboriauSophie Gautier
Jun 29, 2021·Journal of Gastroenterology and Hepatology·Seiji YokoyamaTakayuki Matsumoto
Apr 4, 2018·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alessandro ArmuzziMarco Daperno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.